BRCA1 and cancer: Although the highly methylated cancers showed an average of more than an 8-fold decrease in BRCA1 gene expression compared to BRCA1 proficient cancers (P = 3.6E-8, Fig. 1F), patients with these methylated BRCA1 cancers did poorly with only 3/9 achieving pCR (table S2).